Stryker Corporation $SYK Shares Purchased by Orion Porfolio Solutions LLC

Orion Porfolio Solutions LLC lifted its stake in shares of Stryker Corporation (NYSE:SYK) by 10.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,156 shares of the medical technology company’s stock after purchasing an additional 1,856 shares during the quarter. Orion Porfolio Solutions LLC’s holdings in Stryker were worth $7,974,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in SYK. Thrivent Financial for Lutherans lifted its holdings in shares of Stryker by 12.7% in the 2nd quarter. Thrivent Financial for Lutherans now owns 97,365 shares of the medical technology company’s stock valued at $38,507,000 after buying an additional 10,975 shares during the period. Claris Financial LLC boosted its holdings in Stryker by 4.5% during the second quarter. Claris Financial LLC now owns 766 shares of the medical technology company’s stock worth $303,000 after buying an additional 33 shares in the last quarter. MASTERINVEST Kapitalanlage GmbH purchased a new stake in Stryker during the second quarter worth about $1,921,000. Hilltop Partners LLC grew its position in Stryker by 12.7% during the second quarter. Hilltop Partners LLC now owns 743 shares of the medical technology company’s stock worth $294,000 after buying an additional 84 shares during the period. Finally, Stance Capital LLC purchased a new position in Stryker in the second quarter valued at about $4,141,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other news, CFO Preston Wendell Wells sold 165 shares of Stryker stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total transaction of $60,370.20. Following the completion of the sale, the chief financial officer directly owned 6,694 shares in the company, valued at $2,449,200.72. The trade was a 2.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO William E. Berry, Jr. sold 1,953 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $365.49, for a total transaction of $713,801.97. Following the transaction, the chief accounting officer directly owned 2,833 shares in the company, valued at $1,035,433.17. The trade was a 40.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 522,118 shares of company stock worth $185,381,932 over the last ninety days. 5.20% of the stock is currently owned by corporate insiders.

Stryker Stock Performance

Stryker stock opened at $355.34 on Tuesday. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The company has a market capitalization of $135.89 billion, a price-to-earnings ratio of 46.69, a PEG ratio of 2.51 and a beta of 0.89. The stock has a fifty day moving average of $366.60 and a two-hundred day moving average of $378.26. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.13 and a current ratio of 1.85.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.13 by $0.06. The business had revenue of $6.06 billion for the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The business’s revenue was up 10.2% on a year-over-year basis. During the same period in the prior year, the business earned $2.87 earnings per share. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. This is an increase from Stryker’s previous quarterly dividend of $0.84. Stryker’s dividend payout ratio is 44.15%.

Analyst Ratings Changes

SYK has been the topic of several research analyst reports. Needham & Company LLC reissued a “buy” rating and set a $448.00 price target on shares of Stryker in a research note on Friday, November 14th. Royal Bank Of Canada reiterated an “outperform” rating and set a $435.00 target price on shares of Stryker in a research report on Friday, November 14th. Wells Fargo & Company upped their target price on Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a report on Friday, November 14th. Redburn Partners set a $420.00 price target on Stryker in a research note on Thursday, September 18th. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of Stryker in a research report on Monday, November 3rd. Twelve analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Stryker presently has a consensus rating of “Moderate Buy” and an average target price of $431.83.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.